Catherine Powell To Enhance Women's Health As New Board Member Of Inner State, Inc.

Inner State, Inc., a leading name in the psychedelic biotech sector with a focus on women's health and wellness, has recently announced the appointment of Catherine Powell, a former executive at Airbnb and Disney, to its Board of Directors. This strategic move is expected to leverage Powell's extensive experience in managing large-scale operations to further Inner State's mission. The company is at the forefront of exploring the therapeutic benefits of psilocybin mushrooms, with an eye on a market opportunity that spans over $70 billion, encompassing both the expansive market and female hormone regulation.

As a pre-clinical biotech entity, Inner State specializes in the study and development of psychedelic-producing fungi for drug discovery. Its aim is to harness the untapped potential of psilocybin through adaptogenic nutraceuticals and rigorous scientific research. A notable achievement for Inner State was securing the first American university DEA license in collaboration with The Ohio State University for the cultivation and study of whole psilocybin mushrooms, marking a significant step forward in psychedelic research.

Catherine Powell expressed her enthusiasm about joining Inner State's board during this pivotal period. Her excitement stems from the company's innovative approach to making psilocybin accessible for addressing women's health issues, ranging from cancer to neurological conditions associated with perimenopause and menopause. Powell's near two-decade tenure at Airbnb and Disney has equipped her with invaluable insights into global operations, which she now brings to Inner State.

The addition of Powell to the board is part of Inner State's broader strategy to enhance its advisory panel with experts in women's health. The panel includes Dr. Amanda Holley, former FDA reviewer, Dr. Suzanne Gilberg-Lenz, author of The Menopause Bootcamp, and Dr. Sonny Mattek, head of neuroscience at Inner State. This diverse team is set to drive forward Inner State's commitment to developing innovative treatments that improve the lives of women worldwide.

Inner State, Inc. stands as a pioneer in the psychedelic biotech industry, dedicated to advancing outcomes in women's health and wellness through groundbreaking research and development in psychedelic-producing fungi. For more details on their initiatives or investment opportunities, interested parties are encouraged to visit their website at innerstate.me.